Cost Minimization Of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii In Patients With A Nd B Hemophilia In Presence Of Inhibitors
Abstract
Authors
ME Romero Prada F Gomez de la rosa NJ Alvis-Zakzuk M Carrasquilla-Sotomayor JS Alvis-Zakzuk J Zakzuk-Sierra